These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 15012691

  • 1. Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients.
    Gejyo F, Narita I.
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S45-9. PubMed ID: 15012691
    [Abstract] [Full Text] [Related]

  • 2. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A, Gejyo F.
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [Abstract] [Full Text] [Related]

  • 3. Beta2-microglobulin and renal bone disease.
    Wada T, Miyata T, Sakai H, Kurokawa K.
    Perit Dial Int; 1999 Aug; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [Abstract] [Full Text] [Related]

  • 4. [Amyloidosis in hemodialysis patients].
    Bardin T, Zingraff J, Benoît J, Kuntz D, Drüeke T.
    Presse Med; 1987 May 16; 16(18):907-10. PubMed ID: 2954121
    [Abstract] [Full Text] [Related]

  • 5. Carpal tunnel syndrome caused by amyloid containing beta 2 microglobulin: a new amyloid and a complication of long term haemodialysis.
    McClure J, Bartley CJ, Ackrill P.
    Ann Rheum Dis; 1986 Dec 16; 45(12):1007-11. PubMed ID: 3545104
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S, Gejyo F.
    Biochim Biophys Acta; 2005 Nov 10; 1753(1):4-10. PubMed ID: 16226497
    [Abstract] [Full Text] [Related]

  • 8. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F.
    Rinsho Byori; 2001 Mar 10; 49(3):244-8. PubMed ID: 11307323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High-molecular-mass proteins in haemodialysis-associated amyloidosis.
    Argiles A, Mourad G, Axelrud-Cavadore C, Watrin A, Mion C, Cavadore JC.
    Clin Sci (Lond); 1989 May 10; 76(5):547-52. PubMed ID: 2470544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM, Jaber BL.
    Semin Dial; 2006 May 10; 19(2):105-9. PubMed ID: 16551286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteo-articular manifestations of amyloidosis.
    M'bappé P, Grateau G.
    Best Pract Res Clin Rheumatol; 2012 Aug 10; 26(4):459-75. PubMed ID: 23040361
    [Abstract] [Full Text] [Related]

  • 19. Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on haemodialysis using cellulose membranes.
    Muñoz-Gómez J, Gómez-Pérez R, Llopart-Buisán E, Solé-Arqués M.
    Ann Rheum Dis; 1987 Aug 10; 46(8):573-9. PubMed ID: 3310926
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.